Fusion Pharmaceuticals Inc (FUSN)

Fusion Pharmaceuticals Inc (FUSN) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	100.00% -	2.006	0.034	0.028	0.14
Operating Expenses	32.16% 28.27	21.39	26.75	24.88	24.56
Benefits Costs and Expenses	96.18	-	-	-	25.10
Costs And Expenses	8.22% 23.15	21.39	26.75	24.88	25.10
Operating Income/Loss	45.83% -28.27	-19.39	-26.71	-24.86	-24.42
Nonoperating Income/Loss	26.11% 1.392	1.884	1.293	0.553	-0.54
Income/Loss From Continuing Operations Before Tax	4,895% -96.18	2.006	-25.18	-24.29	-24.96
Income Tax Expense/Benefit, Deferred	430.73% 2.917	-0.882	-0.696	-0.494	-0.651
Income Tax Expense/Benefit	612.25% 1.296	-0.253	-0.245	-0.011	-0.34
Income/Loss From Continuing Operations After Tax	53.57% -26.88	-17.50	-25.42	-24.30	-26.45
Net Income/Loss	63.34% -28.18	-17.25	-25.18	-24.29	-24.62
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.35% 2.5215	69.05	66.28	53.78	0.343
Diluted Average Shares	96.35% 2.5215	69.05	66.28	53.78	0.343
Basic Earnings Per Share	56.00% -0.39	-0.25	-0.38	-0.45	-0.55
Diluted Earnings Per Share	56.00% -0.39	-0.25	-0.38	-0.45	-0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-